Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

01.07.2024

1 Am J Clin Nutr
1 Am J Kidney Dis
2 Biochem Biophys Res Commun
2 BMC Ophthalmol
1 BMJ
1 Circulation
8 Diabet Med
2 Diabetes
13 Diabetes Care
6 Diabetes Obes Metab
8 Diabetologia
1 J Biol Chem
1 J Clin Endocrinol Metab
1 J Diabetes Complications
1 J Hypertens
1 J Nutr
2 Kidney Int
1 Lancet
6 PLoS One



    Am J Clin Nutr

  1. ZHANG JJ, Yu HC, Geng TT, Zhang JJ, et al
    Serum 25-hydroxyvitamin D concentrations, vitamin D receptor polymorphisms, and risk of infections among individuals with type 2 diabetes: a prospective cohort study.
    Am J Clin Nutr. 2024 Jun 22:S0002-9165(24)00541.
    >> Share


    Am J Kidney Dis

  2. LIANG YY, He Y, Wang J, Liu Y, et al
    Social Isolation, Loneliness, and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes Mellitus.
    Am J Kidney Dis. 2024 Jun 24:S0272-6386(24)00839.
    >> Share


    Biochem Biophys Res Commun

  3. XUE TT, Cha HJ, Liu QK, Yang D, et al
    Sirtuin-6 knockout causes exacerbated stalled healing of diabetic ulcers in mice.
    Biochem Biophys Res Commun. 2024;726:150235.
    >> Share

  4. LI Y, Gao S, Guo Z, Chen Z, et al
    Screening of potential drugs for the treatment of diabetic kidney disease using single-cell transcriptome sequencing and connectivity map data.
    Biochem Biophys Res Commun. 2024;725:150263.
    >> Share


    BMC Ophthalmol

  5. LIU J, Liu S, Hui P, Teng S, et al
    Ferrous ascorbate as a potential biomarker for diabetic retinopathy: a vitreous humour metabolomics study.
    BMC Ophthalmol. 2024;24:270.
    >> Share

  6. YUAN Y, Zhu A, Zeng L, Wang X, et al
    Preliminary research on LncRNA ATP2B2-IT2 in neovascularization of diabetic retinopathy.
    BMC Ophthalmol. 2024;24:267.
    >> Share


    BMJ

  7. FU EL, Wexler DJ, Cromer SJ, Bykov K, et al
    SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
    BMJ. 2024;385:e078483.
    >> Share


    Circulation

  8. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
    Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
    Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
    >> Share


    Diabet Med

  9. TAMSETT Z, James S, Brown F, O'Neal DN, et al
    Modifiable factors to prevent severe hypoglycaemic and diabetic ketoacidosis presentations in people with type 1 diabetes.
    Diabet Med. 2024 Jun 24:e15384. doi: 10.1111/dme.15384.
    >> Share

  10. MCGRATH A, Lockhart M, Griffin T, Lynch SA, et al
    'Werner Syndrome foot'-A case series of four Irish Traveller siblings with Werner Syndrome, diabetes mellitus and complex foot disease.
    Diabet Med. 2024 Jun 24:e15390. doi: 10.1111/dme.15390.
    >> Share

  11. OLSEN MT, Rasmussen LM, Bach E, Demir C, et al
    Healthcare professionals' competencies and confidence in managing hospitalized patients with type 2 diabetes.
    Diabet Med. 2024 Jun 25:e15392. doi: 10.1111/dme.15392.
    >> Share

  12. OGANESOVA Z, Pemberton J, Brown A
    Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review.
    Diabet Med. 2024 Jun 26:e15369. doi: 10.1111/dme.15369.
    >> Share

  13. LLOYD M, Temple VA, Foley JT, Yeatman S, et al
    Participation in Special Olympics reduces the rate for developing diabetes in adults with intellectual and developmental disabilities.
    Diabet Med. 2024 Jun 25:e15393. doi: 10.1111/dme.15393.
    >> Share

  14. BASHIR A, Flatt AJ, Richell G, Shaw JAM, et al
    A single-site feasibility randomised controlled trial comparing 'my hypo compass' short pyscho-educational intervention with standard care alone in individuals with type 1 diabetes and impaired awareness of hypoglycaemia.
    Diabet Med. 2024 Jun 26:e15389. doi: 10.1111/dme.15389.
    >> Share

  15. LIU F, Xu X, Sun T
    Vascular endothelial growth factor accelerates healing of foot ulcers in diabetic rats via promoting M2 macrophage polarization.
    Diabet Med. 2024 Jun 27:e15388. doi: 10.1111/dme.15388.
    >> Share

  16. LEWIS SJ, Williams CL, Mortimer GL, Oram RA, et al
    Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis.
    Diabet Med. 2024 Jun 27:e15394. doi: 10.1111/dme.15394.
    >> Share


    Diabetes

  17. D'ALESSIO DA, Kahn SE, Mulder H
    The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature.
    Diabetes. 2024 Jun 24:dbi240034. doi: 10.2337/dbi24-0034.
    >> Share

  18. BYNDLOSS M, Devkota S, Duca F, Hendrik Niess J, et al
    The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications-2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes. 2024 Jun 24:dbi240028. doi: 10.2337/dbi24-0028.
    >> Share


    Diabetes Care

  19. GREEN JB, Crowley MJ, Thirunavukkarasu S, Maruthur NM, et al
    The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice.
    Diabetes Care. 2024 Jun 22:dci240001. doi: 10.2337/dci24-0001.
    >> Share

  20. KAHN SE, Deanfield JE, Jeppesen OK, Emerson SS, et al
    Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
    Diabetes Care. 2024 Jun 22:dc240491. doi: 10.2337/dc24-0491.
    >> Share

  21. LINGVAY I, Deanfield J, Kahn SE, Weeke PE, et al
    Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.
    Diabetes Care. 2024 Jun 22:dc240764. doi: 10.2337/dc24-0764.
    >> Share

  22. D'ALESSIO DA, Kahn SE, Mulder H
    The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature.
    Diabetes Care. 2024 Jun 24:dci240053. doi: 10.2337/dci24-0053.
    >> Share

  23. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.
    Diabetes Care. 2024 Jun 24:dci240042. doi: 10.2337/dci24-0042.
    >> Share

  24. SHAO Y, Wang Y, Bigman E, Imperatore G, et al
    Lifetime Medical Spending Attributed to Incident Type 2 Diabetes in Medicare Beneficiaries: A Longitudinal Study Using 1999-2019 National Medicare Claims.
    Diabetes Care. 2024 Jun 24:dc240466. doi: 10.2337/dc24-0466.
    >> Share

  25. FELEKE BE, Salim A, Morton JI, Gabbe BJ, et al
    Excess Risk of Injury in Individuals With Type 1 or Type 2 Diabetes Compared With the General Population.
    Diabetes Care. 2024 Jun 25:dc240469. doi: 10.2337/dc24-0469.
    >> Share

  26. MERKEL L, Teufel F, Malta DC, Theilmann M, et al
    The Association Between Depressive Symptoms, Access to Diabetes Care, and Glycemic Control in Five Middle-Income Countries.
    Diabetes Care. 2024 Jun 25:dc231507. doi: 10.2337/dc23-1507.
    >> Share

  27. HTOO PT, NajafZadeh M, Tesfaye H, Schneeweiss S, et al
    Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes.
    Diabetes Care. 2024 Jun 25:dc240270. doi: 10.2337/dc24-0270.
    >> Share

  28. WARE J, Boughton CK, Allen JM, Wilinska ME, et al
    Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial.
    Diabetes Care. 2024 Jun 26:dc240360. doi: 10.2337/dc24-0360.
    >> Share

  29. CHEN ZZ, Lu C, Dreyfuss JM, Tiwari G, et al
    Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes.
    Diabetes Care. 2024 Jun 27:dc232441. doi: 10.2337/dc23-2441.
    >> Share

  30. HU J, Pike JR, Lutsey PL, Sharrett AR, et al
    Age of Diabetes Diagnosis and Lifetime Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetes Care. 2024 Jun 27:dc240203. doi: 10.2337/dc24-0203.
    >> Share

  31. CHOI J, Lee H, Kuang A, Huerta-Chagoya A, et al
    Genome-Wide Polygenic Risk Score Predicts Incident Type 2 Diabetes in Women With History of Gestational Diabetes.
    Diabetes Care. 2024 Jun 28:dc240022. doi: 10.2337/dc24-0022.
    >> Share


    Diabetes Obes Metab

  32. ABERER F, Haberl HC, Elsayed H, Pottler T, et al
    Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy.
    Diabetes Obes Metab. 2024 Jun 25. doi: 10.1111/dom.15719.
    >> Share

  33. HAGI K, Kochi K, Watada H, Kaku K, et al
    Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data-driven cluster analysis: A post-hoc analysis of imeglimin clinical trial data.
    Diabetes Obes Metab. 2024 Jun 25. doi: 10.1111/dom.15716.
    >> Share

  34. LUO M, Sun M, Wang T, Wei J, et al
    Type 2 diabetes, glycaemic traits, structural brain capacity and cognitive function: A Mendelian randomization analysis.
    Diabetes Obes Metab. 2024 Jun 25. doi: 10.1111/dom.15702.
    >> Share

  35. AERNOUTS C, Belde SPW, Lambrechts J, Mertens J, et al
    Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes.
    Diabetes Obes Metab. 2024 Jun 25. doi: 10.1111/dom.15723.
    >> Share

  36. AYESH H, Suhail S, Ayesh S, Niswender K, et al
    Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials.
    Diabetes Obes Metab. 2024 Jun 25. doi: 10.1111/dom.15725.
    >> Share

  37. LIU M, Gu W, Chen L, Li Y, et al
    The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial.
    Diabetes Obes Metab. 2024 Jun 22. doi: 10.1111/dom.15724.
    >> Share


    Diabetologia

  38. D'ALESSIO DA, Kahn SE, Mulder H
    The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
    >> Share

  39. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
    Hyperglycaemic crises in adults with diabetes: a consensus report.
    Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
    >> Share

  40. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
    >> Share

  41. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
    The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
    >> Share

  42. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
    Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
    >> Share

  43. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
    Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
    >> Share

  44. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
    Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
    >> Share

  45. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
    >> Share


    J Biol Chem

  46. ZHANG B, Bu C, Wang Q, Chen Q, et al
    Low molecular weight heparin promotes the PPAR pathway by protecting the glycocalyx of cells to delay the progression of diabetic nephropathy.
    J Biol Chem. 2024 Jun 24:107493. doi: 10.1016/j.jbc.2024.107493.
    >> Share


    J Clin Endocrinol Metab

  47. LETH-MOLLER M, Hulman A, Kampmann U, Hede S, et al
    Effect of gestational diabetes on fetal growth rate and later overweight in the offspring.
    J Clin Endocrinol Metab. 2024 Jun 25:dgae428. doi: 10.1210.
    >> Share


    J Diabetes Complications

  48. GEORELI E, Stamati A, Dimitriadou M, Chainoglou A, et al
    Assessment of arterial stiffness in paediatric patients with type 1 diabetes mellitus.
    J Diabetes Complications. 2024;38:108782.
    >> Share


    J Hypertens

  49. MAVROGEORGIS E, Kondyli M, Mischak H, Vlahou A, et al
    Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
    J Hypertens. 2024 Mar 29. doi: 10.1097/HJH.0000000000003726.
    >> Share


    J Nutr

  50. NIINISTO S, Cuthbertson D, Miettinen ME, Hakola L, et al
    High levels of immunoglobulin G against cow's milk proteins and frequency of cow milk consumption are associated with the development of islet autoimmunity and type 1 diabetes - the TRIGR study.
    J Nutr. 2024 Jun 19:S0022-3166(24)00344-4. doi: 10.1016/j.tjnut.2024.
    >> Share


    Kidney Int

  51. DRUEKE TB, Massy ZA
    Unexpected metabolic effects of sodium-glucose cotransporter 2 inhibitors.
    Kidney Int. 2024;106:12-15.
    >> Share

  52. FENG Y, Sun Z, Fu J, Zhong F, et al
    Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury.
    Kidney Int. 2024;106:50-66.
    >> Share


    Lancet

  53. SWEETING A, Hannah W, Backman H, Catalano P, et al
    Epidemiology and management of gestational diabetes.
    Lancet. 2024 Jun 18:S0140-6736(24)00825-0. doi: 10.1016/S0140-6736(24)00825.
    >> Share


    PLoS One

  54. ALBABTAIN B, Paudyal V, Cheema E, Bawazeer G, et al
    Translation, cultural adaptation and validation of Patient Satisfaction with Pharmacist Services Questionnaire (PSPSQ) 2.0 into the Arabic language among people with diabetes.
    PLoS One. 2024;19:e0298848.
    >> Share

  55. IWELOMEN O, Toniolo J, Preux PM, Beloni P, et al
    Therapeutic patient education programs on diabetes in sub-Saharan Africa: A systematic review.
    PLoS One. 2024;19:e0299526.
    >> Share

  56. EL FRAKCHI N, El Kinany K, El Baldi M, Saoud Y, et al
    Association of dietary total antioxidant capacity with general and abdominal obesity in type 2 diabetes mellitus patients.
    PLoS One. 2024;19:e0306038.
    >> Share

  57. OJO OA, Oladepo FS, Ogunlakin AD, Ayokunle DI, et al
    Spilanthes filicaulis (Schumach. & Thonn.) C. D Adam leaf extract prevents assault of streptozotocin on liver cells via inhibition of oxidative stress and activation of the NrF2/Keap1, PPARgamma, and PTP1B signaling pathways.
    PLoS One. 2024;19:e0306039.
    >> Share

  58. ALKHATEEB AA, Mancl LA, Ramos KJ, Rothen ML, et al
    The association between cystic fibrosis-related diabetes and periodontitis in adults: A pilot cross-sectional study.
    PLoS One. 2024;19:e0305975.
    >> Share

  59. ZHAO M, Dong Y, Chen L, Shen H, et al
    Influencing factors of stroke in patients with type 2 diabetes: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305954.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016